Alnylam Teams Up with ChatGPT Creator’s AI Company to Revolutionize RNAi Therapeutics

Alnylam Pharmaceuticals partners with AI startup Inceptive in a deal worth up to $2 billion to accelerate discovery of next-generation RNAi therapeutics using powerful AI models.